- Home
- ELVN vs RVT Comparison
ELVN vs RVT Comparison
Compare ELVN & RVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ELVN | RVT |
|---|---|---|
| Founded | 2016 | 1986 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Trusts Except Educational Religious and Charitable |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.2B | 2.3B |
| IPO Year | 2020 | N/A |
Fundamental Metrics
Financial Performance| Metric | ELVN | RVT |
|---|---|---|
| Price | $40.94 | $17.59 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $43.40 | N/A |
| AVG Volume (30 Days) | ★ 802.4K | 233.9K |
| Earning Date | 05-11-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 7.32% |
| EPS Growth | ★ 3.17 | N/A |
| EPS | N/A | ★ 2.95 |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $5.93 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $14.79 | $14.41 |
| 52 Week High | $48.53 | $18.88 |
Technical Indicators
Market Signals| Indicator | ELVN | RVT |
|---|---|---|
| Relative Strength Index (RSI) | 57.54 | 37.80 |
| Support Level | $38.58 | $17.37 |
| Resistance Level | $41.83 | $17.71 |
| Average True Range (ATR) | 2.20 | 0.38 |
| MACD | 0.04 | -0.11 |
| Stochastic Oscillator | 68.95 | 16.45 |
Price Performance
Historical ComparisonAbout ELVN Enliven Therapeutics Inc.
Enliven Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics. The product candidates of the company include ELVN-001 is designed to specifically target the BCR-ABL fusion gene product, the oncogenic driver for patients with chronic myeloid leukemia (CML), ELVN-002 is designed to inhibit wild-type HER2 and key mutations of HER2.
About RVT Royce Value Trust Inc.
Royce Small-Cap Trust Inc is a diversified closed-end investment company that invests in equity securities of small-cap companies. The company portfolio includes sectors such as Industrials, Financials, Information Technology, Health Care, and Consumer Discretionary.